Publications | UCSF Philip R. Lee Institute for Health Policy Studies

GEFA: Early Fusion Approach in Drug-Target Affinity Prediction.

Nguyen TM, Nguyen T, Le TM, Tran T

IEEE/ACM Trans Comput Biol Bioinform 2022 Mar doi: 10.1109/TCBB.2021.3094217

Content Analysis of Transportation Screening Questions in Social Risk Assessment Tools: Are We Capturing Transportation Insecurity?

Razon N, Gottlieb L

J Am Board Fam Med 2022 Mar doi: 10.3122/jabfm.2022.02.210256

Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access.

Deverka PA, Douglas MP, Phillips KA

Health Aff (Millwood) 2022 Mar doi: 10.1377/hlthaff.2021.01316

Why Add "Abolition" to the National Academies of Sciences, Engineering, and Medicine's Social Care Framework?

Gottlieb LM, Lindau ST, Peek ME

AMA J Ethics 2022 Mar doi: 10.1001/amajethics.2022.170

Patterns of utilization and evaluation of advanced practice providers on academic hospital medicine teams: A national survey.

Shannon EM, Cauley M, Vitale M, Wines L, Chopra V, Greysen SR, Herzig SJ, Kripalani S, O'Leary KJ, Vasilevskis EE, Williams MV, Auerbach AD, Mueller SK, Schnipper JL

J Hosp Med 2022 Mar doi: 10.1002/jhm.12788

Rising to the Challenge: Strategies to Support Latinas and Other Women of Color in Science and Medicine.

Rodriguez CI, Jagsi R, Mangurian C

Acad Med 2022 Mar doi: 10.1097/ACM.0000000000004558

Applying the Digital Health Social Justice Guide.

Figueroa CA, Murayama H, Amorim PC, White A, Quiterio A, Luo T, Aguilera A, Smith ADR, Lyles CR, Robinson V, von Vacano C

Front Digit Health 2022 Feb doi: 10.3389/fdgth.2022.807886

Characterizing the Landscape of Safety Net Programs and Policies in California during the COVID-19 Pandemic.

Jackson KE, Yeb J, Gosliner W, Fernald LCH, Hamad R

Int J Environ Res Public Health 2022 Feb doi: 10.3390/ijerph19052747

Association of Primary Care Engagement in Value-Based Reform Programs With Health Services Outcomes: Participation and Synergies.

Adler-Milstein J, Linden A, Hollingsworth JM, Ryan AM

JAMA Health Forum 2022 Feb doi: 10.1001/jamahealthforum.2022.0005

Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial.

Marseille E, Mitchell JM, Kahn JG

PLoS One 2022 Feb doi: 10.1371/journal.pone.0263252